During the past decade, Kinderwunschzentrum Dortmund conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinderwunschzentrum Dortmund" #1 collaborator was "Datamap" with 1 trials as a collaborator, "Ferring Arzneimittel GmbH" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kinderwunschzentrum Dortmund" are "Female Infertility" (1 trials) and "Infertility" (1 trials). Many other conditions were trialed in "Kinderwunschzentrum Dortmund" in a lesser frequency.

Most popular intervention types in "Kinderwunschzentrum Dortmund" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cetrorelix" (1 trials), "Choriongonadotropin" (1 trials), "Dydrogesterone 30 mg" (1 trials), "Follitrophin alpha" (1 trials) and "Menotrophin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kinderwunschzentrum Dortmund" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kinderwunschzentrum Dortmund". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kinderwunschzentrum Dortmund, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kinderwunschzentrum Dortmund, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".